Status:

RECRUITING

Multidisciplinary Management of Severe COPD

Lead Sponsor:

Vastra Gotaland Region

Conditions:

Copd

COPD Exacerbation

Eligibility:

All Genders

40-100 years

Phase:

NA

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is a common chronic disease that is characterized by persistent airflow limitation, that is due to airway and/or alveolar abnormalities usually caused by s...

Eligibility Criteria

Inclusion

  • Male or female patients, aged ≥40 years.
  • Smokers or ex-smokers (≥10 pack-year).
  • Prior hospitalization because of progressively worsening dyspnea (associated or not with increased cough and sputum, and or sputum purulence), with a clinically suspected diagnosis of exacerbations of COPD that prompt the discharging physician to refer the patient to the COPD Center.
  • Signed informed concent form.

Exclusion

  • Presenting to the hospital for similar symptoms, which are not defined by the clinicians as suspected exacerbations of COPD, because of alternative diagnoses not related to patients with COPD (e.g., chest wall trauma, neurological disorders, sepsis, cancer and anemia).
  • Already enrolled in other studies perceived to interfere with this protocol.
  • In whom spirometry test is contraindicated (e.g., hemoptysis, detached retina, active tuberculosis).
  • Unable to comply with study procedures and follow-ups in the opinion of the Investigator (e.g., other severe diseases with short life expectancy or who make it impossible for the patients to participate into the study, evidence of alcohol or drug abuse, dementia, severe psychiatric disorder).
  • Acute myocardial infarction and unstable angina pectoris or arrhythmias requiring specific cardiology ICU.
  • Diagnosed stroke, dementia, degenerative neurological disorders or psychiatry disorders requiring specialized care.
  • At the discretion of the recruiting clinician would not be able to be considered for the study.

Key Trial Info

Start Date :

September 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2027

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT04860375

Start Date

September 22 2021

End Date

March 31 2027

Last Update

May 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

COPD-Center

Gothenburg, VGR, Sweden